{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:47Z","timestamp":1761154307417},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,24]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The aim of this study was to investigate the possible influence of the tumor necrosis factor alpha (TNFA) gene promoter polymorphisms and HLA class II genes on the susceptibility to or development of human brucellosis. TNFA genotypes (at positions \u2212308 and \u2212238) were determined in 59 patients with brucellosis and 160 healthy controls by polymerase chain reaction-restriction fragment length polymorphism. There were no significant differences between the patients and the controls for the TNFA-238 genotypes. However, when the overall TNFA-308 genotype distribution of the brucella patients was compared with that of the control subjects, a significant skewing was observed (P = 0\u00b702). The TNFA-308.1\/2 genotype was present at significantly higher frequency in the total patient as a whole compared with control subjects (30% versus 15%; P = 0\u00b701, odds ratio (OR) 2\u00b749, 95% confidence interval (CI) 1\u00b716\u20135\u00b733). No statistically significant differences in the distribution of HLA-DRB1 or DQB1 alleles were observed between brucella patients and control subjects. Stratification to correct for interdependence of TNFA-308.2 and HLA-DR3 alleles confirmed that, in spite of their strong linkage disequilibrium, the association of TNFA-308.2 with brucellosis was independent of HLA-DR3.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2000.01331.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:23:20Z","timestamp":1047378200000},"page":"480-483","source":"Crossref","is-referenced-by-count":31,"title":["TNFA promoter polymorphism and susceptibility to brucellosis"],"prefix":"10.1093","volume":"121","author":[{"given":"A","family":"Caballero","sequence":"first","affiliation":[{"name":"Servicio de Inmunolog\u00eda and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Bravo","sequence":"additional","affiliation":[{"name":"Servicio de Inmunolog\u00eda and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Nieto","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina \u2018L\u00f3pez-Neyra\u2019, CSIC, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J D","family":"Colmenero","sequence":"additional","affiliation":[{"name":"Unidad de Enfermedades Infecciosas, Hospital \u2018Carlos Haya\u2019, M\u00e1laga"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Alonso","sequence":"additional","affiliation":[{"name":"Servicio de Inmunolog\u00eda and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina \u2018L\u00f3pez-Neyra\u2019, CSIC, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"2022011221080889200_b1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/infdis\/170.5.1216","article-title":"Changing trends in the epidemiology of human brucellosis in California from to 1973 to 1992: a shift toward foodborne transmission","volume":"170","author":"Chomel","year":"1994","journal-title":"J Infect Dis"},{"key":"2022011221080889200_b2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.16.1.593","article-title":"The immunogenetics of human infectious diseases","volume":"16","author":"Hill","year":"1998","journal-title":"Ann Rev Immunol"},{"key":"2022011221080889200_b3","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/iai.64.7.2782-2786.1996","article-title":"Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms","volume":"64","author":"Zhan","year":"1996","journal-title":"Infect Immun"},{"key":"2022011221080889200_b4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.161.3.1447","article-title":"Control of IL-12 and IFN-\u03b3 production in response to live or dead bacteria by TNF and other factors","volume":"161","author":"Zhan","year":"1998","journal-title":"J Immunol"},{"key":"2022011221080889200_b5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/cimm.1993.1241","article-title":"Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide","volume":"151","author":"Jiang","year":"1993","journal-title":"Cell Immunol"},{"key":"2022011221080889200_b6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/371508a0","article-title":"Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria","volume":"371","author":"McGuire","year":"1994","journal-title":"Nature"},{"key":"2022011221080889200_b7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.182.5.1259","article-title":"Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis","volume":"182","author":"Cabrera","year":"1995","journal-title":"J Exp Med"},{"key":"2022011221080889200_b8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/174.4.878","article-title":"Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease","volume":"174","author":"Nadel","year":"1996","journal-title":"J Infect Dis"},{"key":"2022011221080889200_b9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/517282","article-title":"Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy","volume":"176","author":"Roy","year":"1997","journal-title":"J Infect Dis"},{"key":"2022011221080889200_b10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-0039.1997.tb02715.x","article-title":"Polymorphism at the TNF loci in rheumatoid arthritis","volume":"49","author":"Vinasco","year":"1997","journal-title":"Tissue Antigens"},{"key":"2022011221080889200_b11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.177.2.557","article-title":"An allelic polymorphism within the human tumor necrosis factor \u03b1 promoter region is strongly associated with HLA-A1, B8 and DR3 alleles","volume":"177","author":"Wilson","year":"1993","journal-title":"J Exp Med"},{"key":"2022011221080889200_b12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1529-0131(200001)43:1<129::AID-ANR16>3.0.CO;2-S","article-title":"TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus","volume":"43","author":"Rood","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022011221080889200_b13","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor \u03b1 promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011221080889200_b14","first-page":"32","article-title":"Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation","volume":"46","author":"Brinkman","year":"1995","journal-title":"J Inflamm"},{"key":"2022011221080889200_b15","first-page":"42","article-title":"-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of human TNF promoter","volume":"46","author":"Stuber","year":"1995","journal-title":"J Inflamm"},{"key":"2022011221080889200_b16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/iai.65.3.1003-1006.1997","article-title":"Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF alpha) gene promoter and with elevated TNF alpha levels in tear fluid","volume":"65","author":"Conway","year":"1997","journal-title":"Infect Immun"},{"key":"2022011221080889200_b17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/iai.60.4.1441-1446.1992","article-title":"Tumor necrosis factor production in patients with leprosy","volume":"60","author":"Barnes","year":"1992","journal-title":"Infect Immun"},{"key":"2022011221080889200_b18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(96)06413-6","article-title":"Genetic influence on cytokine production and fatal meningococcal disease","volume":"349","author":"Westendorp","year":"1997","journal-title":"Lancet"},{"key":"2022011221080889200_b19","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4049\/jimmunol.156.8.2885","article-title":"Brucella species release a specific, protease-sensitive, inhibitor of TNF-\u03b1 expression, active on human macrophage-like cells","volume":"156","author":"Caron","year":"1996","journal-title":"J Immunol"},{"key":"2022011221080889200_b20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/352595a0","article-title":"Common West African HLA antigens are associated with protection from severe malaria","volume":"352","author":"Hill","year":"1991","journal-title":"Nature"},{"key":"2022011221080889200_b21","first-page":"1","article-title":"HLA antigens in brucellosis","volume":"2","author":"Pareja","year":"1985","journal-title":"Exp Clin Immunogenet"},{"key":"2022011221080889200_b22","first-page":"621","article-title":"Reactive arthritis associated with brucellosis. HLA studies","volume":"8","author":"Alarc\u00f3n","year":"1981","journal-title":"J Rheum"},{"key":"2022011221080889200_b23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF02031614","article-title":"HLA studies in brucellar spondilytis","volume":"4","author":"Alarc\u00f3n","year":"1985","journal-title":"Clin Rheum"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01331.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01331.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/121\/3\/480\/42129769\/j.1365-2249.2000.01331.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/121\/3\/480\/42129769\/j.1365-2249.2000.01331.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:13:09Z","timestamp":1682050389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/121\/3\/480\/6461668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,10,9]]},"published-print":{"date-parts":[[2001,12,24]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01331.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,9]]},"published":{"date-parts":[[2000,9]]}}}